This case is the Millennium strategic and organizational responses to the rapid development of the biopharmaceutical industry. In the early 2000s, as a competitive advantage in the early stages of the Millennium Research slipped and its losses mounted, the founder CEO Mark Levin firm moved downstream from the research and drug development and commercialization, while narrowing of the horizontal width of more than a dozen therapeutic classes only three. In 2005, Levin hired Deborah Dunsire from Novartis as General Manager to lead the continuing transformation of the millennium. Students are asked to put themselves in the incoming CEO Dunsire and provide organizational recommendations for the new strategy. "Hide
by Julie M. Wolf, Scott Waggoner Source: Harvard Business School 11 pages. Publication Date: February 02, 2010. Prod. #: 710418-PDF-ENG
Related Case Solutions & Analyses:
Embedding Corporate Philanthropy in Grand Circle Corporation
Peer-to-Peer File Sharing and the Market for Digital Information Goods
Lumen and Absorb Teams at Crutchfield Chemical Engineering
The Battle of the Asian Transshipment Hubs: PSversus PTP (A)
Vivendi Universal
Aluminum Smelting in South Africa: Alusafs Hillside Project
General Property Trust
FHP wireless
Yataro Iwasaki: Founding Mitsubishi (A), Portuguese Version
Bayt.com: How Bayt.com Derived a”Place Surplus” in Dubai, U.A.E.
